MiNK Therapeutics, a clinical-stage biopharmaceutical company, is pioneering innovative cancer treatments and immune-mediated disease therapies through its allogeneic iNKT cell therapies.

MiNK Therapeutics is a pioneering biopharmaceutical company that is revolutionizing cancer treatment with its innovative iNKT cell therapies, offering new hope to patients worldwide.